Abstract:Pathological cardiac hypertrophy is associated with many diseases including hypertension. Recent studies have identified important roles for microRNAs (miRNAs) in many cardiac pathophysiological processes, including the regulation of cardiomyocyte hypertrophy. However, the role of miR-145-5p in the cardiac setting is still unclear. In this study, H9C2 cells were overexpressed with microRNA-145-5p, and then treated with Ang-II for 24 h, to study the effect of miR-145-5p on Ang-II-induced myocardial hypertrophy in vitro. Results showed that Ang-II treatment down-regulated miR-145-5p expression were revered after miR-145-5p overexpression. Based on results of bioinformatics algorithms, paxillin was predicted as a candidate target gene of miR-145-5p, luciferase activity assay revealed that the luciferase activity of cells was substantial downregulated the following co-transfection with wild paxillin 3′UTR and miR-145-5p compared to that in scramble control, while the inhibitory effect of miR-145-5p was abolished after transfection of mutant paxillin 3′UTR. Additionally, overexpression of miR-145-5p markedly inhibited activation of Rac-1/ JNK /c-jun/ NFATc3 and ANP expression and induced SIRT1 expression in Ang-II treated H9c2 cells. Jointly, our study suggested that miR-145-5p inhibited cardiac hypertrophy by targeting paxillin and through modulating Rac-1/ JNK /c-jun/ NFATc3/ ANP / Sirt1 signaling, therefore proving novel downstream molecular pathway of miR-145-5p in cardiac hypertrophy

What problem does this paper attempt to address?

This paper aims to explore the role of miR - 145 - 5p in angiotensin II (Ang - II)-induced myocardial pathological hypertrophy and its underlying mechanisms. Specifically, researchers overexpressed miR - 145 - 5p in vitro using the H9c2 cardiomyocyte cell line and observed its effect on Ang - II - induced myocardial hypertrophy. The study found that miR - 145 - 5p inhibits myocardial hypertrophy by targeting paxillin and down - regulating the activation of Rac1, pJNK, p - c - Jun, NFATc3, ANP and up - regulating the expression of Sirt1. ### Research Background - **Hypertension and Cardiac Hypertrophy**: Hypertension is one of the main risk factors for cardiac hypertrophy, and cardiac hypertrophy may eventually lead to heart failure. - **The Role of miRNA**: In recent years, the role of microRNAs (miRNAs) in cardiovascular diseases has gradually attracted attention, especially in regulating cardiomyocyte hypertrophy. - **Research Gaps in miR - 145 - 5p**: Although the role of miR - 145 - 5p in other pathological processes has been reported, its specific role in cardiac hypertrophy remains unclear. ### Research Methods - **Cell Culture and Treatment**: Use the H9c2 cardiomyocyte cell line to overexpress miR - 145 - 5p and treat the cells with Ang - II. - **Western Blot Analysis**: Detect the expression levels of related proteins, including paxillin, Rac1, pJNK, p - c - Jun, NFATc3, ANP and Sirt1. - **Luciferase Reporter Gene Assay**: Verify whether miR - 145 - 5p directly targets the 3'UTR of paxillin. - **Cell Morphology Analysis**: Observe cell morphology changes by Actin staining and evaluate the cell area. ### Main Results - **Expression of miR - 145 - 5p**: In H9c2 cells treated with Ang - II, the expression of miR - 145 - 5p was significantly down - regulated, and overexpression of miR - 145 - 5p could reverse this effect. - **Paxillin as a Target of miR - 145 - 5p**: The luciferase reporter gene assay showed that miR - 145 - 5p could directly target the 3'UTR of paxillin and inhibit its expression. - **Regulation of Signal Pathways**: Overexpression of miR - 145 - 5p significantly inhibited the activation of Rac1, pJNK, p - c - Jun, NFATc3 and ANP and up - regulated the expression of Sirt1. - **Cell Morphology Changes**: Overexpression of miR - 145 - 5p partially restored Ang - II - induced cardiomyocyte hypertrophy, manifested as a decrease in cell area and restoration of normal Actin fiber arrangement. ### Discussion - **The Protective Role of miR - 145 - 5p**: The study shows that miR - 145 - 5p effectively inhibits Ang - II - induced myocardial hypertrophy by targeting paxillin and regulating downstream signal pathways. - **Potential Therapeutic Targets**: miR - 145 - 5p may become a promising target for the treatment of cardiac hypertrophy, but further in vivo experiments and clinical studies are still needed to verify its effectiveness. ### Conclusion This study reveals the important role of miR - 145 - 5p in myocardial hypertrophy, especially by targeting paxillin and regulating the Rac1/pJNK/p - c - Jun/NFATc3/ANP/Sirt1 signal pathway, providing new ideas for the treatment of myocardial hypertrophy.

miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression

Mir-145 Inhibits Isoproterenol-Induced Cardiomyocyte Hypertrophy by Targeting the Expression and Localization of GATA6

Overexpression of Microrna-99a Attenuates Cardiac Hypertrophy

Mir-139-5p Inhibits Isoproterenol-Induced Cardiac Hypertrophy by Targetting C-Jun

Mir-96 Inhibits Cardiac Hypertrophy by Targeting Growth Factor Receptor-Bound 2.

MicroRNA-122-5p Aggravates Angiotensin II-Mediated Myocardial Fibrosis and Dysfunction in Hypertensive Rats by Regulating the Elabela/Apelin-APJ and ACE2-GDF15-Porimin Signaling

miR‐31‐5p suppresses myocardial hypertrophy by targeting Nfatc2ip

MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction

MiR-378 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting AKT2

Abstract 61: Mirna-21 Targets Left Ventricular Peroxisome Proliferator-activated Receptor Alpha in a Rat Model of Type 4 Cardiorenal Syndrome

Cardiac Hypertrophy is Positively Regulated by MicroRNA-24 in Rats

Attenuation of MicroRNA-495 Derepressed PTEN to Effectively Protect Rat Cardiomyocytes from Hypertrophy

Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.

MiRNA-122-5p inhibitor abolishes angiotensin II–mediated loss of autophagy and promotion of apoptosis in rat cardiofibroblasts by modulation of the apelin-AMPK-mTOR signaling

Microrna-340-5p Functions Downstream Of Cardiotrophin-1 To Regulate Cardiac Eccentric Hypertrophy And Heart Failure Via Target Gene Dystrophin

Overexpression of Microrna-26B Attenuates Angiotensin II-induced Cardiac Hypertrophy Through Inhibition of Autophagic Responses.

GW24-e2270 MicroRNA-378 Plays Regulatory Roles in Pressure Overload-induced Cardiac Remodelling

MiR‐26a‐5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.